Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


5AM Partners IV, LLC Create: Alert

All | News | Filings
Date FiledTypeDescription
11/15/2022 4 5AM Partners IV, LLC (10% Owner) has filed a Form 4 on Pear Therapeutics, Inc.
Txns: Sold 28,205 shares @ $3.19, valued at $90k
Sold 1,175 shares @ $3.19, valued at $3.7k
Sold 11,643 shares @ $2.79, valued at $32.5k
Sold 485 shares @ $2.79, valued at $1.4k
Sold 61,222 shares @ $2.52, valued at $154.3k
Sold 2,551 shares @ $2.52, valued at $6.4k
11/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2022 4 5AM Partners IV, LLC (10% Owner) has filed a Form 4 on scPharmaceuticals Inc.
Txns: Sold 30,457 shares @ $5.02, valued at $152.9k
Sold 1,269 shares @ $5.02, valued at $6.4k
Sold 5,808 shares @ $5.02, valued at $29.2k
Sold 456,413 shares @ $4.09, valued at $1.9M
Sold 19,017 shares @ $4.09, valued at $77.8k
Sold 87,036 shares @ $4.09, valued at $356k
09/16/2022 4 5AM Partners IV, LLC (10% Owner) has filed a Form 4 on Pear Therapeutics, Inc.
Txns: Sold 273,664 shares @ $1.94, valued at $530.9k
Sold 11,403 shares @ $1.94, valued at $22.1k
Sold 261,840 shares @ $1.81, valued at $473.9k
Sold 10,910 shares @ $1.81, valued at $19.7k
Sold 337 shares @ $1.75, valued at $589.8
Sold 14 shares @ $1.75, valued at $24.5
09/08/2022 4 5AM Partners IV, LLC (10% Owner) has filed a Form 4 on Pear Therapeutics, Inc.
Txns: Sold 298,714 shares @ $2.36, valued at $705k
Sold 12,446 shares @ $2.36, valued at $29.4k
Sold 148,337 shares @ $1.92, valued at $284.8k
Sold 6,181 shares @ $1.92, valued at $11.9k
Sold 292,149 shares @ $1.81, valued at $528.8k
Sold 12,173 shares @ $1.81, valued at $22k
09/08/2022 4 5AM Partners IV, LLC (10% Owner) has filed a Form 4 on scPharmaceuticals Inc.
Txns: Sold 21,702 shares @ $5.52, valued at $119.8k
Sold 904 shares @ $5.52, valued at $5k
Sold 4,016 shares @ $5.52, valued at $22.2k
Sold 163,034 shares @ $4.75, valued at $774.4k
Sold 6,793 shares @ $4.75, valued at $32.3k
Sold 30,173 shares @ $4.75, valued at $143.3k
08/18/2022 4 5AM Partners IV, LLC (10% Owner) has filed a Form 4 on Pear Therapeutics, Inc.
Txns: Sold 160,476 shares @ $1.78, valued at $285.6k
Sold 6,686 shares @ $1.78, valued at $11.9k
Sold 9,674 shares @ $1.71, valued at $16.5k
Sold 403 shares @ $1.71, valued at $689.1
Sold 213,851 shares @ $1.55, valued at $331.5k
Sold 8,910 shares @ $1.55, valued at $13.8k
04/13/2022 4 5AM Partners IV, LLC (10% Owner) has filed a Form 4 on scPharmaceuticals Inc.
Txns: Sold 220,096 shares @ $5, valued at $1.1M
Sold 9,171 shares @ $5, valued at $45.9k
Sold 40,733 shares @ $5, valued at $203.7k
12/13/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
12/28/2020 4 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on Homology Medicines, Inc.
Txns: Sold 480,000 shares @ $12.82, valued at $6.2M
Sold 20,000 shares @ $12.82, valued at $256.4k
12/16/2020 4 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on Homology Medicines, Inc.
Txns: Sold 151,138 shares @ $13.0609, valued at $2M
Sold 328,862 shares @ $11.88, valued at $3.9M
Sold 6,297 shares @ $13.0609, valued at $82.2k
Sold 13,703 shares @ $11.88, valued at $162.8k
11/13/2020 4 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on IDEAYA Biosciences, Inc.
Txns: Sold 657,117 shares @ $13.66, valued at $9M
Sold 27,379 shares @ $13.66, valued at $374k
Sold 115,504 shares @ $13.66, valued at $1.6M
10/07/2020 4 5AM Ventures IV, L.P. (Former 10% holder) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Sold 175,000 shares @ $25.3, valued at $4.4M
06/18/2020 4 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Sold 115,357 shares @ $33.3, valued at $3.8M
Sold 4,807 shares @ $33.3, valued at $160.1k
Sold 19,836 shares @ $33.3, valued at $660.5k
06/15/2020 4 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Sold 235,200 shares @ $28.7527, valued at $6.8M
Sold 9,800 shares @ $28.7527, valued at $281.8k
05/21/2020 4 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Sold 244,800 shares @ $35.15, valued at $8.6M
Sold 10,200 shares @ $35.15, valued at $358.5k
10/09/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
06/25/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/28/2019 4 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on IDEAYA Biosciences, Inc.
Txns: Converted 1,721,898 shares @ $0
Converted 578,447 shares @ $0
Converted 71,745 shares @ $0
Converted 24,101 shares @ $0
Bought 240,000 shares @ $10, valued at $2.4M
Bought 10,000 shares @ $10, valued at $100k
Bought 500,000 shares @ $10, valued at $5M
Converted 1,721,898 preferred shares @ $0
Converted 578,447 preferred shares @ $0
Converted 71,745 preferred shares @ $0
Converted 24,101 preferred shares @ $0
05/23/2019 3 5AM Ventures IV, L.P. (10% Owner) has filed a Form 3 on IDEAYA Biosciences, Inc.
05/20/2019 4 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on Homology Medicines, Inc.
Txns: Sold 590,400 shares @ $21.47, valued at $12.7M
Sold 24,600 shares @ $21.47, valued at $528.2k
03/20/2019 4 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Sold 148,645 shares @ $24.2507, valued at $3.6M
Sold 6,194 shares @ $24.2507, valued at $150.2k
02/22/2019 4 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Disposed of 451,200 shares @ $0
Disposed of 18,800 shares @ $0
Acquired 4,700 shares @ $0
Disposed of 4,700 shares @ $0
Acquired 940 shares @ $0
Acquired 940 shares @ $0
Acquired 353 shares @ $0
Acquired 587 shares @ $0
Acquired 783 shares @ $0
Acquired 783 shares @ $0
Acquired 783 shares @ $0
01/24/2019 4 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Sold 251,667 shares @ $21.875, valued at $5.5M
Sold 10,486 shares @ $21.875, valued at $229.4k
12/12/2018 4 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on Homology Medicines, Inc.
Txns: Sold 14,952 shares @ $26.0051, valued at $388.8k
Sold 623 shares @ $26.0051, valued at $16.2k
11/27/2018 4 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on Homology Medicines, Inc.
Txns: Sold 28,495 shares @ $20.036, valued at $570.9k
Sold 1,187 shares @ $20.036, valued at $23.8k
11/20/2018 4 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on Homology Medicines, Inc.
Txns: Sold 504,864 shares @ $20.2, valued at $10.2M
Sold 21,036 shares @ $20.2, valued at $424.9k
07/20/2018 4 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns: Converted 2,797,635 shares @ $0
Converted 451,274 shares @ $0
Converted 116,567 shares @ $0
Converted 18,802 shares @ $0
Bought 110,400 shares @ $17, valued at $1.9M
Bought 4,600 shares @ $17, valued at $78.2k
Converted 9,204,220 preferred shares @ $0
Converted 1,484,690 preferred shares @ $0
Converted 383,507 preferred shares @ $0
Converted 61,861 preferred shares @ $0
07/17/2018 3 5AM Ventures IV, L.P. (10% Owner) has filed a Form 3 on Crinetics Pharmaceuticals, Inc.
04/04/2018 4 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on Homology Medicines, Inc.
Txns: Converted 5,392,037 shares @ $0
Converted 4,204,502 preferred shares @ $0
Converted 1,187,535 preferred shares @ $0
03/27/2018 3 5AM Ventures IV, L.P. (10% Owner) has filed a Form 3 on Homology Medicines, Inc.
11/21/2017 4 5AM Partners IV, LLC (10% Owner) has filed a Form 4 on scPharmaceuticals Inc.
Txns: Converted 1,483,107 shares @ $0
Converted 1,011,623 shares @ $0
Bought 628,572 shares @ $14, valued at $8.8M
Converted 61,795 shares @ $0
Converted 42,150 shares @ $0
Bought 26,190 shares @ $14, valued at $366.7k
Converted 10,649,003 preferred shares @ $0
Converted 7,263,649 preferred shares @ $0
Converted 443,708 preferred shares @ $0
Converted 302,652 preferred shares @ $0
11/16/2017 3 5AM Partners IV, LLC (10% Owner) has filed a Form 3 on scPharmaceuticals Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy